Patient Performance and Acceptance of Virtual Reality Visual Field Devices
NCT ID: NCT04786886
Last Updated: 2021-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2019-11-04
2021-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision
NCT04281732
Non-inferiority Study for Visual Field Measurements Using a Virtual Reality Device
NCT04010383
Determining the Clinical Utility of Using Virtual Reality Headsets to Assess Visual Function in Those With Glaucoma.
NCT04273438
Improving Visual Field Deficits With Noninvasive Brain Stimulation
NCT05085210
Study on the Effectiveness and Safety of VRT in Patients With Visual Field Defects
NCT06914505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual Reality Visual Field Group
Participants in this group will have virtual reality visual field testing during standard of care follow-up visit.
VIrtual Reality Visual Field Exam
Virtual reality visual field exam will be administered using the virtual reality headset. Exams can take up to 20 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VIrtual Reality Visual Field Exam
Virtual reality visual field exam will be administered using the virtual reality headset. Exams can take up to 20 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who either have glaucoma, are glaucoma suspects, or have a strong family history of glaucoma
Exclusion Criteria
* Patients under the age of 13
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Miami
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alana L Grajewski
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alana Grajewski, MD
Role: PRINCIPAL_INVESTIGATOR
University of Miami
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bascom Palmer Eye Institute
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20190679
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.